No automated study selection, meta-analysis or quantitative data pooling was performed
There are concerns about GLP-1 and GLP-1/GIP medications being purchased without a prescription through unregulated or illicit channels, with very light medical supervision or being used outside their licensed use (i.e
Ledesma G, Umpierrez GE, Morley JE, Lewis-DAgostino D, Keller A, Meinicke T, et al
If you cannot commit to daily administration, consider protocols that explicitly include off days (like 5 days on, 2 days off)
We also recommend you consult your healthcare practitioner before taking Altrient R-ALA if you are taking glucose lowering medication, or receiving treatment for under-active or over-active thyroid
See the research library for Certificates of Analysis, HPLC, LC-MS identity testing, purity versus identity, and batch verification plus the analytical testing glossary